ARG1 and hepatocellular carcinoma: Our study showed that the expression of plasma ARG1 in unresectable HCC patients is negatively correlated with the probability of early TACE refractoriness, that is, the higher the expression of plasma ARG1, the lower the risk of early TACE refractoriness and the better the prognosis.